Search

Your search keyword '"Sola P."' showing total 93 results

Search Constraints

Start Over You searched for: Author "Sola P." Remove constraint Author: "Sola P." Language undetermined Remove constraint Language: undetermined
93 results on '"Sola P."'

Search Results

1. Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom

2. Signs and symptoms of COVID-19 in patients with multiple sclerosis

3. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression (vol 208, 106180, 2021)

4. Multi-messenger characterization of Mrk 501 during historically low X-ray and $γ$-ray activity

6. Multiwavelength behaviour of the blazar 3C279: decade-long study from $��$-ray to radio

7. of Therapeutic Lag in Relapsing Multiple Sclerosis

8. Predicting long-term sustained disability progression in multiple sclerosis

9. Modifiers of the effectiveness of MS immunotherapies

10. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

11. Introducing Machine Learning for full MS patient trajectories improves predictions for disability score progression

12. Contribution of inflammation to disability accrual in primary progressive multiple sclerosis

13. Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years

14. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

15. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene

16. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

17. Cerebrospinal fluid findings in Devic?s neuromyelitis optica

20. [Mitochondrial DNA deletion in a case of progressive ophthalmoplegia]

23. Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis

24. The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis

28. Disability trajectories in relapsing-remitting multiple sclerosis

32. Clinical and therapeutic predictors of relapse and disability outcomes in neuromyelitis optica spectrum disorder

33. Determinants of MS re-activation after discontinuing therapies

34. Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models

35. Autologous hematopoietic stem cell transplantation reduces disability progression in patients with secondary progressive multiple sclerosis: results from the Italian MS Register

36. 10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort

38. Aggressive form of multiple sclerosis can be predicted early after disease onset

41. Determinants of therapeutic lag in relapsing multiple sclerosis

42. Anti-inflammatory disease modifying treatment does not attenuate disability progression in secondary progressive multiple sclerosis

43. Risk of secondary progressive multiple sclerosis: a longitudinal study

44. Disability accrual in primary-progressive & secondary-progressive multiple sclerosis

45. Early clinical predictors of severe MS

46. Multiple Sclerosis Severity Score (MSSS) helps predict relapses and recovery from disability in patients treated for multiple sclerosis in the MSBase model

47. Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis

49. Comparative analysis of MS outcomes in natalizumab-treated patients using a novel three-way multinomial propensity score match

Catalog

Books, media, physical & digital resources